Trial Profile
Phase III Study of Acetyl-L-Carnitine (ALC) Hydrochloride Enteric-coated Tablets in Treatment of Peripheral Sensory Neuropathy in Anti-cancer Chemotherapeutics Induce
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Levacecarnine (Primary)
- Indications Peripheral neuropathies
- Focus Registrational; Therapeutic Use
- Sponsors Lee's Pharmaceutical
- 17 Apr 2014 New trial record